Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Flatiron Health Inc.
Headquarters: New York, NY, United States of America
Website: N/A
Year Founded: 2012
Status: Acquired
BioCentury | Dec 18, 2024
Management Tracks
David Apelian becomes CEO of Theolytics
Plus: John McDonough to resign as chairman from BioPorto, and updates from Caris, FibroGen, Akari and Xilio
BioCentury | Jun 28, 2024
Finance
Venture Report: Curie.Bio’s fund; megarounds for Formation, EvolutionaryScale, BillionToOne
Plus: New fundings for Exsilio, TwoStep and Augustine
BioCentury | Jul 27, 2022
Regulation
Global regulators look to integrate real-world evidence into regulatory decision-making
Regulators from 13 countries agree to harmonize RWE use
BioCentury | Jul 21, 2022
Management Tracks
Roche CEO Schwan stresses digital future as he hands baton to Schinecker
Diagnostics chief inherits kernels of digital growth, with revenues and pipeline to ease the path
BioCentury | Apr 1, 2022
Management Tracks
Reed, Maraganore to join Takeda’s board
Plus Merck’s Frazier joins Eikon as independent director, and updates from Transgene and Syapse
BioCentury | Dec 17, 2021
Product Development
How digital is evolving at pharmas
The definition of digital is coming into focus at pharmas as data science becomes the central value driver
BioCentury | Jun 25, 2021
Politics, Policy & Law
Abernethy’s appointment sheds light on Verily’s plans
Verily to develop clinical research tools, conduct research for itself and others
BioCentury | Jun 4, 2021
Management Tracks
Abernethy brings deep experience to Verily as firm readies to build ‘evidence generation platform’
Amy Abernethy has become the second high-profile FDA veteran to join Verily in the past three years. She joins FDA Commissioner Rob Califf, who arrived at the company in November 2019, and heads
BioCentury | May 28, 2021
Product Development
Aligning on the advancement of real-world evidence
RWE Alliance members aim to provide a united voice on how regulators can deploy real-world evidence in decision-making
BioCentury | May 19, 2021
Deals
May 19 Quick Takes: AI play Exscientia expands BMS collaboration; plus HiberCell, eureKARE and RWE Alliance
Less than a month after raising a $525 million series D round led by Softbank, Oxford, U.K.-based AI play Exscientia Ltd. has expanded its collaboration with Bristol Myers Squibb Co. (NYSE:BMY) to
Items per page:
1 - 10 of 60